Rajat Bannerji

Interleukin 2 gene transfer into tumor cells abrogates tumorigenicity and induces protective immunity.

Bernd Gänsbacher, Karen S. Zier, Brian Daniels et al. · The Journal of Experimental Medicine · 1990 · 624 citations · Full text

Immunology, Immune Regulation, Immunologic Mechanism +19

Retroviral vector-mediated gamma-interferon gene transfer into tumor cells generates potent and long lasting antitumor immunity.

Bernd Gänsbacher, Rajat Bannerji, Brian F. Daniels et al. · PubMed · 1990 · 413 citations

Immunology, Immunoediting, Immunologic Mechanism +18

Fixed-duration ibrutinib plus venetoclax for first-line treatment of CLL: primary analysis of the CAPTIVATE FD cohort

Constantine S. Tam, John N. Allan, Tanya Siddiqi et al. · Blood · 2022 · 216 citations · Full text

Primary Endpoint, Pathology, First-line Treatment +19

Regression of bladder tumors in mice treated with interleukin 2 gene-modified tumor cells.

James R. Connor, Rajat Bannerji, Shigeru Saito et al. · The Journal of Experimental Medicine · 1993 · 208 citations · Full text

Immunology, Gene-modified Tumor Cells, Pathology +17

Immunotherapy of prostate cancer in the Dunning rat model: use of cytokine gene modified tumor vaccines.

Johannes Vieweg, Felicia M. Rosenthal, Rajat Bannerji et al. · PubMed · 1994 · 181 citations

Immunology, Immunologic Mechanism, Immunotherapy +16